Pompe disease is characterized by a deficiency of acid α-glucosidase (GAA). The GAA enzyme degrades lysosomal glycogen, and insufficient GAA activity causes glycogen to accumulate in various tissues.
Pompe disease treatment market grows with advances in ERT and gene therapy, improving patient outcomes and access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback